<i>In vitro</i>and<i>in vivo</i>inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors

Monica Benvenuto(University of Rome Tor Vergata), Roberto Bei(University of Rome Tor Vergata)
Oncotarget
January 28, 2016
Cited by 111


Related Papers